5th Jan 2009 14:50
ValiRx plc
(the "Company")
Issue of equity
The Company announces that it has issued a total of 378,606 new ordinary shares of 6p each in the Company ("Ordinary Shares") to certain of its creditors who have agreed for the Company to satisfy, in aggregate, £23,618.15 of their outstanding fees by the issue of new Ordinary Shares. The Ordinary Shares were issued for the following amounts:
|
Number of Ordinary Shares |
Price per Ordinary Share |
Total fees converted |
|
|
21,505 |
7.75p |
£1,666.64 |
|
|
23,810 |
7.00p |
£1,666.70 |
|
|
22,988 |
7.25p |
£1,666.63 |
|
|
310,303 |
6.00p |
£18,618.18 |
|
|
Total |
378,606 |
£23,618.15 |
|
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 January 2009.
Following the issue of the new Ordinary Shares, the Company has 58,378,365 Ordinary Shares in issue.
For further information please contact:
|
ValiRx plc Dr. Satu Vainikka |
Tel: +44 (0) 20 3008 4416 |
|
WH Ireland Limited |
Tel: +44 (0) 161 832 2174 |
|
David Youngman / Adrian Kirk |
|
|
College Hill |
Tel: +44 (0) 20 7457 2020 |
|
Adrian Duffield / Justine Lamond |
Related Shares:
ValiRx